Researchers have been excited about this new drug, a novel dual agonist showing remarkable data in early trials for size reduction . It works by modulating both hormones : GLP-1 and GIP, which , when engaged , support regulate cravings and enhance metabolism . Initial reports demonstrate considerable size reduction and potential advantages for indi